Kerry Rees, patent attorney and partner at HGF, will be talking about patent infringement and freedom to operate in the life science area. If attendees are interested in the topic, Kerry has proposed to organise an IP due diligence workshop on the back of this.
12:00-12.05: Introduction about HGF by Kerry
12:05-12:35: Patent infringement
12:35-12:50: Freedom to operate and infringement risk
12:50-1:00: Questions and closing remarks (introduction to proposed due diligence workshop).
HGF offers the dynamic intellectual property service that every innovative and competitive organisation requires, wherever they are and whenever they need it. Their approach, from the inception of ideas to the enforcement of IP rights is truly collaborative. Their unique and successful client relationships come from our strategic teams that fit around each client’s requirements.
Kerry’s primary focus is patent drafting, prosecution, opposition and appeals before the European Patent Office but he also has extensive experience in all phases of foreign patent prosecution. He also provides FTO/infringement advice.
He undertakes work in a wide variety of technology areas including pharmaceuticals, biologicals, chemistry and biochemistry, microbiology, cell and molecular biology, immunology and medical devices.
Kerry acts for a wide range of clients including start-ups and investors, research institutions, universities and spin-outs, mid-size companies and international corporations. He co-ordinates the filing and prosecution of large patent portfolios whilst keeping a keen eye on ensuring that protection is commercially aligned to business aims across the entirety of the portfolio.
Kerry particularly enjoys working with start-ups and SMEs to develop IP strategies which support the business plan and to secure commercially relevant IP whether that be to secure funding, increase growth and market share or to support a particular exit plan. Kerry joined HGF in 2020 bringing around 20 years’ experience in the patent profession. He graduated from the University of Oxford with a Masters degree in Molecular and Cellular Biochemistry with research experience in extracellular matrix and cell binding interactions.